Landos Biopharma (LABP) Institutional Ownership → The #1 Crypto That You Don’t Own… Yet (From Crypto 101 Media) (Ad) Free LABP Stock Alerts $22.93 +0.13 (+0.57%) (As of 05/23/2024) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Landos Biopharma (NASDAQ:LABP)CurrentInstitutional OwnershipPercentage49.06%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$1.61MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$56.07M Get LABP Insider Trade Alerts Want to know when executives and insiders are buying or selling Landos Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LABP Institutional Buying and Selling by Quarter Ad Porter & CompanyThe only financial event in 2024 that matters Man Who Predicted 2008 Crash Warns of Black Swan Financial Event in 2024 Porter Stansberry’s new documentary is going viral.Stream the documentary for free by clicking here Landos Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/20/2024 Virtu Financial LLC14,537$313K0.0%N/A0.464% 5/16/2024 Black Maple Capital Management LP10,405$223K0.1%N/A0.332% 4/17/2024 Deltec Asset Management LLC50,000$1.07M0.2%N/A1.603% 8/24/2023 Perceptive Advisors LLC1,486,991$6.26M0.2%-90.0%47.660% 11/14/2022 RTW Investments LP3,975,722$2.58M0.1%-7.0%9.876% 11/1/2022OUP Management Co. LLC1,237,667$804K1.3%-23.3%3.074% Get the Latest News and Ratings for LABP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Landos Biopharma and its competitors with MarketBeat's FREE daily newsletter. 10/31/2022 Green Square Capital Advisors LLC84,500$55K0.0%N/A0.210% 7/19/2022OUP Management Co. LLC1,612,764$1.17M1.6%-11.7%4.006% 3/3/2022 Walleye Capital LLC105,208$505K0.0%N/A0.262% 2/10/2022 Acadian Asset Management LLC8,274$39K0.0%N/A0.021% 2/3/2022OUP Management Co. LLC1,827,478$8.77M4.0%N/A4.555% 11/12/2021 Geode Capital Management LLC112,933$1.65M0.0%-11.4%0.282% 11/12/2021 Botty Investors LLC128,750$1.88M0.6%+4.9%0.321% 11/9/2021 BlackRock Inc.233,616$3.41M0.0%-20.6%0.582% 11/4/2021 Deutsche Bank AG2,693$39K0.0%-30.0%0.007% 11/2/2021 Cambridge Investment Research Advisors Inc.18,831$275K0.0%N/A0.047% 11/2/2021 New York State Common Retirement Fund2,756$40K0.0%-62.5%0.007% 11/2/2021 Allworth Financial LP5,286$77K0.0%N/A0.013% 10/22/2021 Strs Ohio11,400$166K0.0%+660.0%0.028% 8/17/2021 Logos Global Management LP899,106$10.39M0.9%+22.5%2.241% 8/16/2021 Tudor Investment Corp Et Al17,793$206K0.0%-71.3%0.044% 8/16/2021 State Street Corp92,367$1.07M0.0%+88.1%0.230% 8/13/2021 Botty Investors LLC122,781$1.42M0.5%+26.0%0.306% 8/13/2021 Geode Capital Management LLC127,518$1.47M0.0%+15.3%0.318% 8/13/2021 Vanguard Group Inc.305,185$3.52M0.0%+61.9%0.761% 8/11/2021 Bank of New York Mellon Corp14,029$162K0.0%+37.8%0.035% 8/11/2021 BlackRock Inc.294,043$3.40M0.0%+14.7%0.733% 5/27/2021Davidson Kempner Capital Management LP50,000$480K0.0%N/A0.125% 5/19/2021 Logos Global Management LP734,000$7.07M0.7%N/A1.830% 5/19/2021 Squarepoint Ops LLC15,361$148K0.0%N/A0.038% 5/18/2021 Zimmer Partners LP90,100$868K0.0%N/A0.225% 5/18/2021 Tudor Investment Corp Et Al61,899$596K0.0%N/A0.154% 5/18/2021 Orbimed Advisors LLC681,000$6.56M0.1%N/A1.697% 5/18/2021Davidson Kempner Capital Management LP50,000$480K0.0%N/A0.125% 5/18/2021 Old Well Partners LLC18,316$176K0.1%N/A0.046% 5/18/2021 California State Teachers Retirement System9,518$92K0.0%N/A0.024% 5/17/2021 Deerfield Management Company L.P. Series C450,000$4.33M0.1%N/A1.122% 5/17/2021 Perceptive Advisors LLC17,960,839$159.69M2.0%N/A44.770% 5/17/2021 Woodline Partners LP213,335$2.05M0.0%N/A0.532% 5/17/2021 Caas Capital Management LP40,000$385K0.0%N/A0.100% LEAKED: Jeff Bezos' $330 Million Gamble (Ad)Did you know that 3 simple words are disrupting a $62.7 billion market? "Blood Brain Barrier" Seems innocent enough.Here's how you could invest alongside them >>>5/17/2021 Nuveen Asset Management LLC10,219$98K0.0%N/A0.025% 5/17/2021 Sphera Funds Management LTD.70,000$674K0.1%N/A0.174% 5/14/2021 Laurion Capital Management LP10,000$96K0.0%N/A0.025% 5/14/2021 RTW Investments LP4,275,722$38.33M0.6%N/A10.658% 5/14/2021 Monashee Investment Management LLC91,309$879K0.1%N/A0.228% 5/13/2021 Bank of New York Mellon Corp10,182$98K0.0%N/A0.025% 5/13/2021 Botty Investors LLC97,477$939K0.3%N/A0.243% 5/12/2021 Northern Trust Corp74,359$716K0.0%N/A0.185% 5/12/2021 Geode Capital Management LLC110,559$1.06M0.0%N/A0.276% 5/12/2021 Ensign Peak Advisors Inc125,000$1.20M0.0%N/A0.312% 5/12/2021 JPMorgan Chase & Co.375,021$3.61M0.0%N/A0.935% 5/11/2021 Teacher Retirement System of Texas10,000$96K0.0%N/A0.025% 5/11/2021 New York State Common Retirement Fund7,300$70K0.0%N/A0.018% 5/7/2021 BlackRock Inc.256,290$2.47M0.0%N/A0.639% 5/7/2021 American International Group Inc.3,677$35K0.0%N/A0.009% (Data available from 1/1/2016 forward) LABP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LABP shares? During the previous two years, the following institutional investors and hedge funds held shares of Landos Biopharma shares: Perceptive Advisors LLC ($6.26M), RTW Investments LP ($2.58M), Deltec Asset Management LLC ($1.07M), OUP Management Co. LLC ($804K), Virtu Financial LLC ($313K), and Black Maple Capital Management LP ($223K), and Green Square Capital Advisors LLC ($55K).Learn more on LABP's institutional investors. What percentage of Landos Biopharma stock is owned by institutional investors? 49.06% of Landos Biopharma stock is owned by institutional investors. Learn more on LABP's institutional investor holdings. Which institutional investors have been buying Landos Biopharma stock? The following institutional investors have purchased Landos Biopharma stock in the last 24 months: Green Square Capital Advisors LLC ($84.50K), Deltec Asset Management LLC ($50K), Virtu Financial LLC ($14.54K), and Black Maple Capital Management LP ($10.41K). How much institutional buying is happening at Landos Biopharma? Institutional investors have bought a total of 159,442 shares in the last 24 months. This purchase volume represents approximately $2.16M in transactions. Which Landos Biopharma major shareholders have been selling company stock? The following institutional investors have sold Landos Biopharma stock in the last 24 months: Perceptive Advisors LLC ($13.38M), OUP Management Co. LLC ($589.81K), and RTW Investments LP ($300K). How much institutional selling is happening at Landos Biopharma? Institutional investors have sold a total of 14,272,735 shares in the last 24 months. This volume of shares sold represents approximately $62.03M in transactions. Related Companies: Achilles Therapeutics Major Shareholders Aspira Women's Health Major Shareholders Sensei Biotherapeutics Major Shareholders Gossamer Bio Major Shareholders Adverum Biotechnologies Major Shareholders Nature's Sunshine Products Major Shareholders Xeris Biopharma Major Shareholders Aquestive Therapeutics Major Shareholders Revance Therapeutics Major Shareholders ESSA Pharma Major Shareholders This page (NASDAQ:LABP) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Landos Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.